ADA Scientific Sessions 2026 Abstract·6 JunATR-258, a GRK2-Biased ß2AR Modulator, Mitigates Worsening of Insulin Resistance in Type 2 Diabetes after Metformin WithdrawalTrial in peopleInterventionsPaper